TREA

86284654 - CELL-SELECTOR

Follow

Information

  • Trademark
  • 86284654
  • Serial Number
    86284654
  • Registration Number
    4897070
  • Filing Date
    May 19, 2014
    10 years ago
  • Registration Date
    February 09, 2016
    9 years ago
  • Transaction Date
    September 27, 2022
    2 years ago
  • Status Date
    August 19, 2022
    2 years ago
  • Published for Opposition Date
    April 21, 2015
    9 years ago
  • Location Date
    February 09, 2016
    9 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SWIFT, GILBERT M
  • Attorney Docket Number
    435467US
    Attorney Name
    Jeffrey H. Kaufman
    Law Office Assigned Location Code
    L90
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CELL-SELECTOR
Case File Statements
  • GS0051: Pharmaceutical preparations for pharmaceutical and veterinary purposes for the treatment of hematological, respiratory, central nervous system, endocrinological, circulatory and hormonal disorders, rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, anti-infective disorders, sarcoidosis, subacute myelo-optico-neuropathy, aortitis syndrome, inflammatory bowel disease, amyloidosis, striatonigral degeneration and for use in oncology; Pharmaceutical preparations for pharmaceutical and veterinary purposes for the prevention of hematological, respiratory, central nervous system, endocrinological, circulatory and hormonal disorders, rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, anti-infective disorders, sarcoidosis, subacute myelo-optico-neuropathy, aortitis syndrome, inflammatory bowel disease, amyloidosis, striatonigral degeneration and for use in oncology; Tumor suppressing agents; Anti-cancer preparations; Anti-sarcoma preparations; Pharmaceutical preparations for animals for the treatment of hematological and respiratory disorders, immune system disorders and related diseases, allergic reactions, anti-infective disorders, and for use in oncology; Pharmaceutical preparations for animals for the prevention of hematological and respiratory disorders, immune system disorders and related diseases, allergic reactions, anti-infective disorders, and for use in oncology; chemical reagents for medical diagnostic purposes; nucleic acid and oligonucleotide for medical and medical diagnostic purposes; chemical reagents and reagent kit comprised of nucleic acid, oligonucleotide, deoxyribonucleic acid, protein, medical diagnostic reagents and buffers used for detection of nucleic acid for medical and medical diagnostic purposes; chemical reagents and reagent kits comprised of nucleic acid, oligonucleotide, deoxyribonucleic acid, protein, medical diagnostic reagents and buffers used for the detection of protein for medical and medical diagnostic purposes; chemical reagents and reagent kits comprised of nucleic acid, oligonucleotide, deoxyribonucleic acid, protein, medical diagnostic reagents and buffers used for staining cells for medical and medical diagnostic purposes
  • GS0011: Chemical preparations for general industrial manufacturing and for scientific purpose; Chemical preparations for scientific purpose and for scientific research purposes; Chemical agents for scientific purpose and research purpose, namely, chemical agents for binding cells or protein, chemical agents for chelating and sequestering; Diagnostic reagents for scientific or research purposes, other than for medical or veterinary purposes; Chemical reagents, other than for medical or veterinary purposes; Reagents used for analyzing, measuring or testing nucleotide for scientific research purposes; chemical reagents used for staining cells other than for medical or veterinary use; chemical reagent kits comprised of nucleic acid, oligonucleotide, deoxyribonucleic acid, protein, and buffers for use in biotechnology fields used for staining cells other than for medical or veterinary use; chemical reagents and reagent kits comprised of nucleic acid, oligonucleotide, deoxyribonucleic acid, protein, and buffers for use in biotechnology fields used for the detection of protein; nucleic acid and oligonucleotide for scientific research purposes; deoxyribonucleic acid for laboratory use; Protein for industrial use; enzymes for in vitro and in vivo scientific and research purposes; biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes
Case File Event Statements
  • 8/19/2022 - 2 years ago
    25 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 2/9/2021 - 4 years ago
    24 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 9/19/2018 - 6 years ago
    23 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 2/9/2016 - 9 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/31/2015 - 9 years ago
    21 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 11/11/2015 - 9 years ago
    20 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 12/21/2015 - 9 years ago
    19 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 11/11/2015 - 9 years ago
    18 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR
  • 6/16/2015 - 9 years ago
    17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/21/2015 - 9 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/21/2015 - 9 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/1/2015 - 10 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/18/2015 - 10 years ago
    13 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 3/9/2015 - 10 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/23/2015 - 10 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/23/2015 - 10 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/16/2015 - 10 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 2/10/2015 - 10 years ago
    8 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/10/2015 - 10 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/12/2014 - 10 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/12/2014 - 10 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/12/2014 - 10 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/12/2014 - 10 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/2/2014 - 10 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 5/22/2014 - 10 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP